XML 46 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisition Of Prostiva Radio Frequency Therapy (Pro-Forma Financial Information) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Jun. 30, 2012
Acquisition Of Prostiva Radio Frequency Therapy [Abstract]  
Pro forma net revenue $ 18,283
Pro forma net loss $ (4,960)
Pro forma net loss per share (basic) $ (0.34)
Pro forma net loss per share (diluted) $ (0.34)